1. Home
  2. VIR vs ABR Comparison

VIR vs ABR Comparison

Compare VIR & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.82

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$5.35

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
ABR
Founded
2016
2003
Country
United States
United States
Employees
N/A
653
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
VIR
ABR
Price
$8.82
$5.35
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$19.43
$9.90
AVG Volume (30 Days)
1.6M
3.8M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
15.42%
EPS Growth
17.49
N/A
EPS
N/A
N/A
Revenue
$68,556,000.00
N/A
Revenue This Year
$270.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.29
Revenue Growth
N/A
N/A
52 Week Low
$4.16
$4.73
52 Week High
$11.66
$12.58

Technical Indicators

Market Signals
Indicator
VIR
ABR
Relative Strength Index (RSI) 42.38 49.72
Support Level $8.43 $4.99
Resistance Level $10.33 $5.43
Average True Range (ATR) 0.45 0.18
MACD -0.02 0.04
Stochastic Oscillator 20.78 74.77

Price Performance

Historical Comparison
VIR
ABR

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

Share on Social Networks: